Biotech · Private company
Amphivena Therapeutics, Inc.
Track this companyFree. Adds Amphivena Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AMV564Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- AMV564Phase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- AMV564 14-Day CIVPhase 1 · Myelodysplastic Syndrome (MDS)ClinicalTrials.gov · fetched Nov 12, 2026
- AMV564 in combination with pembrolizumabPhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of AMV564 in Subjects With Advanced Solid TumorsPHASE1 · UNKNOWN · started Oct 9, 2019ClinicalTrials.gov NCT04128423 · fetched Nov 12, 2026
- A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic SyndromesPHASE1 · COMPLETED · started Jun 22, 2018ClinicalTrials.gov NCT03516591 · fetched Nov 12, 2026
- Study of AMV564 in Patients With AMLPHASE1 · COMPLETED · started Mar 20, 2017ClinicalTrials.gov NCT03144245 · fetched Nov 12, 2026